Studies are often done by pharmaceutical companies to determine the effectiveness of a treatment program. Suppose that a new AIDS antibody drug is currently under study. It is given to patients once the AIDS symptoms have revealed themselves. Of interest is the average (mean) length of time in months patients live once they start the treatment. Two researchers each follow a different set of 4040 patients with AIDS from the start of treatment until their deaths. The following data (in months) are collected.

Researcher A:

3; 4; 11; 15; 16; 17; 22; 44; 37; 16; 1414; 24; 25; 15; 26; 27; 33; 29; 35; 44; 13; 21; 22; 10; 12; 8; 40; 32; 26; 27; 31; 34; 29; 17; 8; 24; 47; 47; 33; 34

Researcher B:

3; 14; 11; 5; 16; 17; 28; 41; 31; 18; 14; 14; 26; 25; 21; 22; 31; 2; 35; 44; 23; 21; 21; 16; 12; 18; 41; 22; 16; 25; 33; 34; 29; 13; 18; 24; 23; 42; 33; 29

Determine what the key terms refer to in the example for Researcher A.

--12345	parameter		--12345	variable		--12345	sample
--12345	statistic		--12345	population

1.		AIDS patients
2.		The average length of time (in months) AIDS patientslive after treatment in the sample.
3.		The average length of time (in months) AIDS patients live after treatment.
4.		The4040 AIDS patients in the study.
5.		X=the length of time (in months) AIDS patients live after treatment.